Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial-Reference-Cited by-同舟云学术

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial

Published:2013-05 Issue:9877 Volume:381 Page:1541-1550
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Gabay Cem,Emery Paul,van Vollenhoven Ronald,Dikranian Ara,Alten Rieke,Pavelka Karel,Klearman Micki,Musselman David,Agarwal Sunil,Green Jennifer,Kavanaugh Arthur

Publisher

Elsevier BV

Subject

General Medicine

Reference39 articles.

1. Long term safety of methotrexate monotherapy in rheumatoid arthritis patients: a systematic literature research;Salliot;Ann Rheum Dis,2009

2. How well do patients with rheumatoid and psoriatic arthritis tolerate methotrexate? A retrospective review of discontinuation data from a large UK cohort;Goudie;Arthritis Rheum,2012

3. Merging Veterans Affairs rheumatoid arthritis registry and pharmacy data to assess methotrexate adherence and disease activity in clinical practice;Cannon;Arthritis Care Res,2011

4. Compliance with methotrexate treatment in patients with rheumatoid arthritis: influence of patients' beliefs about the medicine: a prospective cohort study;de Thurah;Rheumatol Int,2010

5. Adherence to disease-modifying antirheumatic drugs and the effects of exposure misclassification on the risk of hospital admission;Grijalva;Arthritis Care Res,2010

Cited by 555 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing withdrawal strategies for anti-TNF-α therapies in rheumatoid arthritis;Expert Opinion on Biological Therapy;2024-07-25

2. A common secretomic signature across epithelial cancers metastatic to the pleura supports IL-6 axis therapeutic targeting;Frontiers in Immunology;2024-07-24

3. Understanding Autoimmunity: Mechanisms, Predisposing Factors, and Cytokine Therapies;International Journal of Molecular Sciences;2024-07-12

4. Biologics or Janus Kinase Inhibitors in Rheumatoid Arthritis Patients Who are Insufficient Responders to Conventional Anti-Rheumatic Drugs;Drugs;2024-07-01

5. Actualización del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas y sintéticas dirigidas en la artritis reumatoide;Reumatología Clínica;2024-07